News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Taveras Arthur
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/13/2023 |
4
| Taveras Arthur (Chief Scientific Officer) has filed a Form 4 on X4 Pharmaceuticals, Inc|
Txns:
| Sold 16,806 shares
@ $0.84, valued at
$14.1k
|
|
| 11/09/2022 |
4
| Taveras Arthur (Chief Scientific Officer) has filed a Form 4 on X4 Pharmaceuticals, Inc|
Txns:
| Granted 1,000,000 rights
@ $1.8, valued at
$1.8M
|
|
| 03/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/25/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/01/2020 |
4
| Taveras Arthur (Chief Scientific Officer) has filed a Form 4 on X4 Pharmaceuticals, Inc|
Txns:
| Granted 121,150 options to buy
@ $6.6, valued at
$799.6k
|
|
| 11/03/2020 |
3
| Taveras Arthur (Chief Scientific Officer) has filed a Form 3 on X4 Pharmaceuticals, Inc |
|
|